| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.026 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.024 | 0.9 |